We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACH
651
Accendra Health
ACH
$85.4M
$3.14M 0.01%
92,300
+2,600
+3% +$89.1K
GNCA
652
DELISTED
Genocea Biosciences, Inc.
GNCA
$3.13M 0.01%
20,836
– –
BXP icon
653
Boston Properties
BXP
$10.2B
$3.12M 0.01%
26,388
+1,502
+6% +$177K
AMD icon
654
Advanced Micro Devices
AMD
$823B
$3.11M 0.01%
742,400
-853,100
-53% -$3.46M
A icon
655
Agilent Technologies
A
$42.4B
$3.1M 0.01%
75,355
+27,905
+59% +$1.12M
CVD
656
DELISTED
COVANCE INC.
CVD
$3.06M 0.01%
35,748
-724
-2% -$64.5K
NBL
657
DELISTED
Noble Energy, Inc.
NBL
$3.04M 0.01%
39,294
+5,544
+16% +$404K
WNR
658
DELISTED
Western Refining Inc
WNR
$3M 0.01%
80,000
+20,000
+33% +$806K
THO icon
659
Thor Industries
THO
$3.71B
$3M 0.01%
52,722
-5,300
-9% -$318K
DBV
660
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$3M 0.01%
114,880
+16,070
+16% +$420K
LTM
661
DELISTED
LIFE TIME FITNESS INC
LTM
$2.92M 0.01%
59,900
– –
URI icon
662
United Rentals
URI
$61.6B
$2.91M 0.01%
27,802
-64,209
-70% -$6.28M
DOV icon
663
Dover
DOV
$25.5B
$2.91M 0.01%
39,616
+1,486
+4% +$104K
MCO icon
664
Moody's
MCO
$80.9B
$2.9M 0.01%
33,064
+14,177
+75% +$1.17M
AKAO
665
DELISTED
Achaogen Inc
AKAO
$2.89M 0.01%
207,046
+40,000
+24% +$560K
AGIO icon
666
Agios Pharmaceuticals
AGIO
$1.96B
$2.88M 0.01%
62,741
– –
CDE icon
667
Coeur Mining
CDE
$20.5B
$2.83M 0.01%
307,741
– –
ENH
668
DELISTED
Endurance Specialty Holdings Ltd
ENH
$2.81M 0.01%
54,400
+8,400
+18% +$437K
ADI icon
669
Analog Devices
ADI
$175B
$2.8M 0.01%
51,800
+7,300
+16% +$386K
EWP icon
670
iShares MSCI Spain ETF
EWP
$2.22B
$2.8M 0.01%
65,421
– –
SPB icon
671
Spectrum Brands
SPB
$1.97B
$2.8M 0.01%
32,500
+17,900
+123% +$1.4M
SANM icon
672
Sanmina
SANM
$10.3B
$2.77M 0.01%
121,500
+3,300
+3% +$66.8K
CPB icon
673
Campbell Soup
CPB
$6.37B
$2.74M 0.01%
59,796
+20,265
+51% +$915K
IGOV icon
674
iShares International Treasury Bond ETF
IGOV
$1.52B
$2.73M 0.01%
51,890
+15,280
+42% +$794K
VR
675
DELISTED
Validus Hold Ltd
VR
$2.73M 0.01%
71,300
-213,378
-75% -$7.94M
25 26
27
28 29

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.